The Standalone and Consolidated Financial results of the company for the quarter and financial year ended 31st March, 2025 along with the Audit report issued by the Statutory auditor are attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Riddhi Siddhi Gluco Biols Ltd reported its audited FY25 results with a sharp drop in operating revenue from ₹22,094 lakhs to ₹9,138 lakhs on a standalone basis, a fall of nearly 59%, as the Trading Business segment wound down. However, profit after tax edged up marginally to ₹9,412 lakhs (vs ₹9,223 lakhs in FY24), supported by strong other income (mainly dividends and interest from investments) of about ₹12,056 lakhs. EPS rose slightly to ₹132.01 from ₹129.36. The Board has recommended a dividend of ₹3 per share (30%) and approved large related party transactions with Bluecraft Agro Pvt Ltd – purchase/sale of goods up to ₹500 crore per annum for 5 years, and investments or guarantees up to ₹350 crore. Auditor Batliboi & Purohit issued an unmodified (clean) opinion but flagged an Emphasis of Matter on an income tax dispute where ₹308 lakhs is treated as a contingent liability.
The headline revenue collapse looks alarming on the surface, but earnings are propped up by investment income, so the business is essentially a treasury/holding entity now. The bigger watch-outs for shareholders are the rising current borrowings (up ~58% to ₹8,841 lakhs), a sizeable negative operating cash flow of -₹3,748 lakhs, an ongoing tax litigation (₹308 lakhs contingent), and pending SEBI matters linked to Minimum Public Shareholding compliance. The proposed related party deals with Bluecraft Agro are significant and will require shareholder approval.